These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3658991)

  • 1. Characterization of premalignant changes in the prostate.
    McNeal JE
    Prog Clin Biol Res; 1987; 239():703-9. PubMed ID: 3658991
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant change in hyperplastic prostate glands. The AFIP experience.
    Mostofi FK; Sesterhenn IA; Davis CJ
    Urology; 1989 Dec; 34(6 Suppl):49-51. PubMed ID: 2481363
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostatic "dysplasia/atypical hyperplasia". Terminology, histopathology, pathobiology, and significance.
    Kastendieck H; Helpap B
    Urology; 1989 Dec; 34(6 Suppl):28-42. PubMed ID: 2481361
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical hyperplasia of prostate.
    Kovi J; Mostofi FK
    Urology; 1989 Dec; 34(6 Suppl):23-7. PubMed ID: 2481360
    [No Abstract]   [Full Text] [Related]  

  • 5. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
    Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
    Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precancerous conditions of the prostate--histologic and morphometric investigation].
    Gundorova LV
    Vopr Onkol; 2003; 49(6):738-42. PubMed ID: 14976919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies.
    Kastendieck H
    Pathol Res Pract; 1980 Nov; 169(3-4):366-87. PubMed ID: 7220384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation between dysplastic lesions and latent cancers of the prostate. An analysis of 100 autopsies].
    Schütze U
    Z Urol Nephrol; 1984 Sep; 77(9):529-35. PubMed ID: 6209871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of prostatic carcinoma. II. The relation between precancerous lesions and carcinoma of the prostate].
    Wu RL
    Zhonghua Zhong Liu Za Zhi; 1984 May; 6(3):189-91. PubMed ID: 6210185
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dyshormonal hyperplasia of the prostate gland and cancer].
    Griunval'd-Agafdnova DL
    Vopr Onkol; 1969; 15(5):54-9. PubMed ID: 4188197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underwriting implications of premalignant disease.
    Vecchione L
    J Insur Med; 1998; 30(3):169-74. PubMed ID: 10351177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
    Cheng L; Shan A; Cheville JC; Qian J; Bostwick DG
    Cancer Res; 1998 Feb; 58(3):389-91. PubMed ID: 9458077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometric diagnostics of the prostate precancer and cancer by examination of ploidy].
    Gundorova LV; Avtandilov GG; Saniev KB; Zaĭrat'iants OV
    Arkh Patol; 2003; 65(4):46-50. PubMed ID: 14518195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epithelial and stromal cell relation in peritumorous zone of the prostate gland cancer].
    Fedoseenko KV; Pecherskiĭ AV; Karpishchenko AI
    Tsitologiia; 2004; 46(8):710-3. PubMed ID: 15598017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AGNOR analyses of prostate carcinomas of high and malignancy].
    Helpap B; Riede C
    Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On latent cancer of the prostate gland according to sutopsy observations].
    Bialik VL; Bialik VV; Kleĭn EG; Ryb'iakova EG
    Arkh Patol; 1968; 30(10):38-44. PubMed ID: 4235860
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.